Indicated for the treatment of chronic hypoparathyroidism in adults.
NOW APPROVED IN AUSTRALIA
For assistance with forgotten passwords or access issues, please contact your regional ST Liaison or email our Marketing and Comms team at planger@stbiopharma.com